BRICKELL BIOTECH, INC. Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementBrickell Biotech, Inc. • March 9th, 2021 • Biological products, (no disgnostic substances) • New York
Brickell Biotech, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc. and William Blair & Company, L.L.C. (each an “Agent” and together, the “Agents”) as follows (defined terms not otherwise defined shall have the meaning set forth in Section 25 of this Agreement):
Brickell Biotech, Inc. Reconciliation and tie between Trust Indenture Act of 1939 and Indenture, dated as of [_____________]Brickell Biotech, Inc. • March 9th, 2021 • Biological products, (no disgnostic substances) • New York
